[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337199-105":59,"doc-detail-337199-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","mir-363-3p-induces-tamoxifen-resistance-in-breast-cancer-cells-through-pten-modulation-research-paper","MiR-363-3p induces tamoxifen resistance in breast cancer cells through PTEN modulation - Research paper","","Tamoxifen resistance in estrogen receptor–positive breast cancer remains a major therapeutic barrier, prompting investigation into its underlying molecular drivers. This study defined the role of microRNA-363-3p in tamoxifen resistance, comparing MCF-7 cells with tamoxifen-resistant MCF-7-TAM cells using high-throughput miRNA sequencing. miR-363-3p increased in resistant cells and directly targeted PTEN, suppressing growth and accelerating apoptosis to enhance tamoxifen sensitivity. Pathway enrichment highlighted PI3K/AKT signaling, linking miR-363-3p–PTEN regulation to endocrine resistance mechanisms. ",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mir-363-3p-induces-tamoxifen-resistance-in-breast-cancer-cells-through-pten-modulation-research-paper/337199/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mir-363-3p-induces-tamoxifen-resistance-in-breast-cancer-cells-through-pten-modulation-research-paper/337199.png","ImageObject",300,407,{"name":92,"@type":93},"Theodora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-16","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main goal of the study on tamoxifen resistance?","Question",{"text":113,"@type":114},"The study aims to clarify how miRNA-363-3p contributes to tamoxifen resistance in breast cancer and to define the related mechanism.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does miR-363-3p affect PTEN in breast cancer cells?",{"text":118,"@type":114},"In MCF-7 cells, miRNA-363-3p directly targets and negatively regulates PTEN, which reduces tamoxifen responsiveness via a PI3K-Akt-associated mechanism.",{"name":120,"@type":111,"acceptedAnswer":121},"What experimental evidence supports the link between miR-363-3p and tamoxifen sensitivity?",{"text":122,"@type":114},"High-throughput miRNA sequencing showed higher miR-363-3p in MCF-7-TAM cells, and manipulating miR-363-3p altered growth and apoptosis, enhancing or reducing sensitivity to tamoxifen. KEGG analysis also enriched PI3K/AKT signaling target genes.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},337199,1790159045,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},687197207919,"https://ap-avatar.wpscdn.com/avatar/a000253d6f5f7c60be?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779446848396160552","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nMiR-363-3p induces tamoxifen resistance in breast cancer cells through PTEN modulation  \nYaning Liang1, Cuiyu Shi1, Yu Wang2, Bingjie Fan3, Wei Song1 & Rong Shen1􀀍  \nNowadays, the investigation for overcoming tamoxifen (TAM) resistance is confronting a considerable challenge. Therefore, immediate attention is required to elucidate the mechanism underlying TAM resistance in breast cancer. This research primarily aimed to define how miRNA-363-3p facilitates resistance toTAM in breast cancer. High-throughput miRNA sequencing was performed using RNAs prepared from breast cancer MCF-7 cells and TAM-resistant MCF-7 cells (MCF-7-TAM). An increase in miRNA-363-3p levels was observed in MCF-7-TAM cells. In MCF-7 cells, miRNA-363-3p directly targeted and negatively regulated phosphatase and tensin homolog (PTEN) . Reduction of miRNA- 363-3p retarded cell growth and accelerated cell apoptosis, thereby enhancing the sensitivity of TAM. Moreover, analysis using the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway showed significant enrichment of target genes within the phosphoinositide-3-kinase (PI3K)/protein kinase B (AKT) signaling pathway. Ultimately, miR-363-3p decreased the responsiveness of breast cancer cells to TAM by targeting and suppressing PTEN through a mechanism associated with the PI3K-Akt pathway. Therefore, these results suggest that miR-363-3p-dependent PTEN expression contributes to the mechanisms underlying breast cancer endocrine resistance.  \nKeywords Hsa-miR-363-3p, Breast cancer, PTEN, TAM resistance, PI3K/AKT signaling pathway  \nBreast cancer is the most prevalently diagnosed cancer in women1, which leads the greatest number of cancerrelated fatalities among women over 45. Its morbidity and mortality are anticipated to rise significantly over the subsequent 5 to 10 years, reflecting the sluggish advancement in the prevention and treatment of this disease2,3. The majority of breast cancer cases are estrogen receptor (ER) positive, which is associated with the highest mortality rates among breast cancer patients4. Tamoxifen (TAM) is the primary treatment for this type of breast cancer. It suppresses tumor cell growth by competitively binding to ER, forming a stable complex that effectively impedes DNA replication in the nucleus and playing a significant role in averting contralateral breast cancer. A 5-year regimen of TAM has been shown to reduce breast cancer mortality by over one-third within the first 15 years. However, some patients with ER-positive early breast cancer develop novel or acquired drug resistance, resulting in tumor recurrence and metastasis5. Therefore, exploring the mechanisms underlying TAM resistance in breast cancer is of paramount significance.  \nMicroRNAs (miRNAs), a class of short non-coding RNAs, could modulate mRNA expression either by targeting their 3′ non-coding regions or by promoting their degradation6. miRNAs have been demonstrated to bo involved in tumorigenesis, metastasis, and drug resistance7. For instance, miR-29a reversed drug resistance induced by p-glycoprotein and decelerated the growth of colon cancer cells by upregulating phosphatase and tensin homolog (PTEN)8. Conversely, activation of the miR-371/372/373 cluster enhanced malignancy and decreased drug sensitivity in oral cancer cells9. A study indicated that miR-378a-3p contributes to TAM resistance in breast cancer by modulating GOLT1A10. miR-663b modulated breast cancer sensitivity to TAM by mediating tumor protein 73 (TP73) expression11. Monopolar spindle 1 promoted breast tumor resistance to TAM by phosphorylating estrogen receptor α4. Therefore, it is crucial to investigate whether other miRNAs can mediate TAM resistance and to explore the underlying mechanisms.  \nmiR-363-3p has been found to be aberrantly expressed in several cancers, including liver cancer12, gastric cancer13, and glioma14. It belongs to the miR-106a-363 cluster15","cbCait6Bm6dnNzGw","https://ap.wps.com/l/cbCait6Bm6dnNzGw","pdf",8515726,14,"English","# Abstract\n# Introduction\n# MicroRNAs and tamoxifen resistance\n# miR-363-3p background in cancers\n# Materials and methods\n## Cells and main reagents","[{\"question\":\"What is the main goal of the study on tamoxifen resistance?\",\"answer\":\"The study aims to clarify how miRNA-363-3p contributes to tamoxifen resistance in breast cancer and to define the related mechanism.\"},{\"question\":\"How does miR-363-3p affect PTEN in breast cancer cells?\",\"answer\":\"In MCF-7 cells, miRNA-363-3p directly targets and negatively regulates PTEN, which reduces tamoxifen responsiveness via a PI3K-Akt-associated mechanism.\"},{\"question\":\"What experimental evidence supports the link between miR-363-3p and tamoxifen sensitivity?\",\"answer\":\"High-throughput miRNA sequencing showed higher miR-363-3p in MCF-7-TAM cells, and manipulating miR-363-3p altered growth and apoptosis, enhancing or reducing sensitivity to tamoxifen. KEGG analysis also enriched PI3K/AKT signaling target genes.\"}]","MiR-363-3p induces tamoxifen resistance in breast cancer cells through PTEN modulation - Research paper | PDF",1790018111,35,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/02da59854709840a6cfa1e2d8280265b.webp",983,1291,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cc2d2b8cb759cea1b6cea64b3496fb03.webp",982,1290,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ab6265ae2a17c228036caee5d81f472c.webp",981,1289,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aae4a2634876383f528901d2b6e4a744.webp",980,1287]